^SAMPLE = GSM590105!Sample_title = BT474 genomic DNA!Sample_geo_accession = GSM590105!Sample_status = Public on Jan 11 2011!Sample_submission_date = Sep 02 2010!Sample_last_update_date = Jan 12 2011!Sample_type = genomic!Sample_channel_count = 2!Sample_source_name_ch1 = pooled genomic DNA from healthy female donors!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = sample type: pooled genomic DNA from healthy female donors!Sample_characteristics_ch1 = gender: female!Sample_growth_protocol_ch1 = MCF-7, KPL-4 and BT-474 cells were maintained in DMEM supplemented with 10% FBS, 2 mM (MCF-7, KPL-4) or 4 mM (BT-474) L-glutamine and penicillin/streptomycin. BT-474 cells were further supplemented with 1 mM sodium pyruvate and 0.01 mg/ml bovine insulin. SK-BR-3 cells were maintained in McCoyâs 5A medium with 10% FCS, 1.5 mM L-glutamine and penicillin/streptomycin.!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Genomic DNA was extracted using TRIzol and purified by chloroform extraction and subsequent ethanol precipitation.!Sample_label_ch1 = Cy3!Sample_label_protocol_ch1 = 3 Î¼g of digested sample or reference DNA (female genomic DNA, Promega) was labeled with Cy5-dUTP and Cy3-dUTP respectively using a Genomic DNA Enzymatic Labeling Kit.!Sample_source_name_ch2 = genomic DNA from breast cancer cell line BT474!Sample_organism_ch2 = Homo sapiens!Sample_taxid_ch2 = 9606!Sample_characteristics_ch2 = gender: female!Sample_characteristics_ch2 = cell line: BT474!Sample_growth_protocol_ch2 = MCF-7, KPL-4 and BT-474 cells were maintained in DMEM supplemented with 10% FBS, 2 mM (MCF-7, KPL-4) or 4 mM (BT-474) L-glutamine and penicillin/streptomycin. BT-474 cells were further supplemented with 1 mM sodium pyruvate and 0.01 mg/ml bovine insulin. SK-BR-3 cells were maintained in McCoyâs 5A medium with 10% FCS, 1.5 mM L-glutamine and penicillin/streptomycin.!Sample_molecule_ch2 = genomic DNA!Sample_extract_protocol_ch2 = Genomic DNA was extracted using TRIzol and purified by chloroform extraction and subsequent ethanol precipitation.!Sample_label_ch2 = Cy5!Sample_label_protocol_ch2 = 3 Î¼g of digested sample or reference DNA (female genomic DNA, Promega) was labeled with Cy5-dUTP and Cy3-dUTP respectively using a Genomic DNA Enzymatic Labeling Kit.!Sample_hyb_protocol = Labelled tumor and reference samples were combined and hybridized onto the arrays according to manufacturer's (Agilent) instructions. After hybridization, arrays were washed according to manufacturer's instructions.!Sample_scan_protocol = Arrays were scanned using a laser scanner from Agilent Technologies. Signal intensities were quantified using the Feature Extraction software from Agilent.!Sample_data_processing = Agilent Feature Extraction Software was used for spot quality filtering and normalization.!Sample_platform_id = GPL8736!Sample_contact_name = Henrik,,Edgren!Sample_contact_email = henrik.edgren@helsinki.fi!Sample_contact_institute = Institute for Molecular Medicine, University of Helsinki!Sample_contact_address = Tukholmankatu 8!Sample_contact_city = Helsinki!Sample_contact_zip/postal_code = 00290!Sample_contact_country = Finland!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM590nnn/GSM590105/suppl/GSM590105_bt474.130209_252152911064_S01_CGH_105_Dec08.txt.gz!Sample_series_id = GSE23949!Sample_data_row_count = 974016#ID_REF = #VALUE = normalized log10 ratio Cy5/Cy3!sample_table_beginID_REF	VALUE1	8.533090322e-0022	0.000000000e+0003	0.000000000e+0004	-3.858315220e-0015	-4.028137750e-0026	-1.665497428e-0017	-9.849206789e-0028	-2.698719820e-0029	-7.052825133e-00210	-2.133191120e-00111	-2.685545878e-00112	-4.928502704e-00213	2.748450632e-00114	-1.345927489e-00115	-1.361532228e-00116	-8.487176249e-00217	6.703984005e-00218	2.160880362e-00119	3.483061280e-00220	2.340992163e-001!sample_table_end